Switch to:
More From Other Websites
Cancer Genetics (CGIX) Shows Strength: Stock Gains 5.8% - Tale of the Tape Apr 13 2015
New Book by Industry Thought Leaders Advocates for Re-Engineering Clinical Trials Apr 13 2015
New Book by Industry Thought Leaders Advocates for Re-Engineering Clinical Trials Apr 13 2015
New Book by industry Thought Leaders Advocates for Re-Engineering Clinical Trials Apr 13 2015
MedAssets: A Strong Sell on Tepid View, Estimate Revision - Analyst Blog Apr 09 2015
Air Methods Now a Strong Buy: Is It in Your Portfolio? - Analyst Blog Mar 27 2015
Is ICON Public Limited (ICLR) a Great Growth Stock? - Tale of the Tape Mar 24 2015
ICON and Carnegie Mellon University Collaborate to Evaluate Patient-centric Informed Consent... Mar 23 2015
ICON and Carnegie Mellon University Collaborate to Evaluate Patient-centric Informed Consent... Mar 23 2015
Biogen, Five Other Top Stocks Show No Sign Of Slowing Mar 20 2015
ICON PLC Financials Mar 19 2015
Why ICON Public Limited (ICLR) Could Beat Earnings Estimates Again - Tale of the Tape Mar 19 2015
ICON Launches Medical Device, Diagnostics Research Group - Analyst Blog Mar 12 2015
ICON Raised to Strong Buy on Stellar Q4, Strategic Acquisition - Analyst Blog Mar 11 2015
ICON Launches Medical Device & Diagnostics Research Group Mar 09 2015
ICON Launches Medical Device & Diagnostics Research Group Mar 09 2015
Irish Highlanders: Drug Stocks Mallinckrodt, Horizon Pharma Rally Mar 05 2015
ICON Plc (ICLR) Shares March Higher, Can It Continue? - Tale of the Tape Mar 05 2015
ICON (ICLR) Posts Stellar Q4 Earnings, Revenues Rise Y/Y - Analyst Blog Mar 03 2015
3 Healthcare Services Stocks Poised to Outperform in 2015 - Stocks in the News Mar 02 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK